AlphaLiquid® HRR is a liquid biopsy-based genomic profiling assay covering HRR (homologous recombination repair) genes for the purpose of therapy selection in advanced stage prostate/breast/ovarian and other cancer patients treated with PARP(Poly ADP ribose polymerase) inhibitor. The test analyses genomic alterations including SNVs and InDels of HRR genes.